
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Neurology® Podcast
00:00
Innovative Treatment for GCA
This chapter explores the complexities of managing giant cell arteritis (GCA) and the limitations of current steroid therapies. It presents a clinical trial for ubatacitinib, demonstrating its potential to achieve sustained remission in GCA patients more effectively than traditional treatments.
Transcript
Play full episode